Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
about
Classical and novel biomarkers for cardiovascular risk prediction in the United StatesDeveloping risk prediction models for kidney injury and assessing incremental value for novel biomarkersIdentifying novel biomarkers for cardiovascular disease risk predictionCRP in cardiovascular diseaseCoronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohortsPrognosis Research Strategy (PROGRESS) 3: prognostic model researchA common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular eventsIncremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality predictionA genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levelsThe association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohortEarly Detection System of Vascular Disease and Its Application ProspectCystatin C and Cardiovascular Disease: A Mendelian Randomization Study.Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.Molecular approaches in obesity studiesCirculating progenitor cell count for cardiovascular risk stratification: a pooled analysis.Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves.Automatic Characterization of the Physiological Condition of the Carotid Artery in 2D Ultrasound Image Sequences Using Spatiotemporal and Spatiospectral 2D MapsMild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.Utilization of genetic data can improve the prediction of type 2 diabetes incidence in a Swedish cohort.Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals.Biomarkers and cardiovascular risk assessment for primary prevention: an update.A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons.Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.Novel cardiovascular risk markers in women with ischaemic heart disease.Assessing the Incremental Role of Novel and Emerging Risk Factors.Applying measures of discriminatory accuracy to revisit traditional risk factors for being small for gestational age in Sweden: a national cross-sectional study.Endothelial function as a functional expression of cardiovascular risk factors.N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohortA multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses.Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesRelation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT TrialImmune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
P2860
Q26824026-06D93E72-733E-4E9E-8E4C-7B0E26B0A084Q26824759-DDB3EF1A-C1C2-4D84-8055-2AC8A04743D2Q26865722-549A72B3-5D1E-438D-A76F-43275145DDB3Q28268282-7A82D76D-52C7-4FC0-9A9E-B9455CD01B4EQ28686330-F396E397-5FF9-4F32-81AC-2D8799D4F699Q28709215-21F8A0A6-9A9E-48B9-A863-2DD3907BAE70Q28729163-16D91AD4-DB91-4E2C-B5E7-9EF31D06F535Q28731264-1B62F4D3-57D8-42C6-8A02-B866F7F38D94Q28731542-B6C0E8DB-8B69-4452-B65E-30E67698CAFDQ28742141-AFF008DA-B93F-4EAE-8EF7-05E5D93A42F0Q30239836-D6DF1CEF-7FA5-443E-9D38-15E8A2E57F0EQ30276065-E249F65D-F537-414A-BEC1-28F7343A8624Q31126960-92611714-2CB2-4D2F-8BC1-A903F4A47790Q33576883-DACBA3A5-1BD6-4DCF-B2F7-28C7371229EBQ33596708-AB46B074-478D-4EAA-9352-85D53E37634DQ33633882-249C5C3F-D5D8-419A-A53D-DC46C8A19012Q33729360-58535C8F-1246-487A-B742-7D68C17B0847Q33757510-74C6645E-DBE4-41F5-AF31-2C76235E3B1DQ33819382-BF03A88D-E0A9-46A2-86FD-CAF59FEA93DEQ33848664-7ABFFC0D-A030-490D-B491-3F33A0B90A51Q33869378-24462A89-C70D-4552-A25F-D428EA52D026Q33898388-BA30AF93-4B66-4315-BBDF-229446DCF0FAQ33917180-EF088546-B043-43F9-AC93-9A9841720B20Q33927398-FCE3490B-E3C0-452C-B356-A2B088CBA4C8Q33931813-EF99051B-225B-4A0D-8667-3C5E9B63D766Q33932928-857F09BC-A2C0-4B45-8460-152739CD239FQ33948944-C1FA0B17-9AB4-453C-B74E-573662C16282Q33972551-D3415B16-A102-4383-9891-E390083AFF39Q33990767-46555352-F0A8-4C0F-8A8D-1B50A27D0A01Q33995037-C88644D5-4117-402D-8228-A13D4D565B07Q33995565-DB6D9445-CABC-4BDE-B3FB-A97B253A7315Q33996015-764ABD74-405D-4B67-8401-B52C28BEF0E2Q34027133-849F625A-6414-49AA-80E0-1B0F418B3013Q34080669-C67A96CD-E1F5-407A-B930-B5704A7EF8A8Q34145381-A72E12EB-9996-44FD-BDAE-4DFA8F76FDC7Q34231061-34AE3876-FC4E-4FBD-9095-0C3AA8B03D8FQ34340697-DE98562E-371F-4410-BFF6-B65E4EB63E19Q34381858-BA2C4342-CF96-4227-AA0F-185293279119Q34412603-5107BB77-7332-4902-B6D2-37C7B7D7E465Q34421298-480DF355-EBBB-4D1E-9606-D516E9333F66
P2860
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel and conventional biomark ...... cular events in the community.
@ast
Novel and conventional biomark ...... cular events in the community.
@en
Novel and conventional biomark ...... cular events in the community.
@nl
type
label
Novel and conventional biomark ...... cular events in the community.
@ast
Novel and conventional biomark ...... cular events in the community.
@en
Novel and conventional biomark ...... cular events in the community.
@nl
prefLabel
Novel and conventional biomark ...... cular events in the community.
@ast
Novel and conventional biomark ...... cular events in the community.
@en
Novel and conventional biomark ...... cular events in the community.
@nl
P2093
P2860
P50
P356
P1476
Novel and conventional biomark ...... cular events in the community.
@en
P2093
Anders Christensson
Andreas Bergmann
Bo Hedblad
Göran Berglund
J Gustav Smith
Joachim Struck
Nils G Morgenthaler
Peter Almgren
Thomas J Wang
P2860
P356
10.1001/JAMA.2009.943
P407
P50
P577
2009-07-01T00:00:00Z